SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration

Jakob Hartmann(Harvard University), Thomas Bajaj(University of Bonn), Joy Otten(Harvard University), Claudia Klengel(Harvard University), Tim Ebert(University of Bonn), Anne‐Kathrin Gellner(University of Bonn), Ellen Junglas(University of Bonn), Kathrin Hafner(Max Planck Institute of Psychiatry), Elmira Anderzhanova(University of Bonn), Fiona Tang(Harvard University), Galen Missig(Harvard University), Lindsay Rexrode(University of Mississippi Medical Center), Daniel T. Trussell(University of Mississippi Medical Center), Katelyn X. Li(Harvard University), Max L. Pöhlmann(Harvard University), Sarah Mackert(University of Bonn), Thomas Geiger(Technische Universität Darmstadt), Daniel E. Heinz(University of Bonn), Roy Lardenoije(Harvard University), Nina Dedic(Harvard University), Kenneth M. McCullough(Harvard University), Tomasz Próchnicki(University Hospital Bonn), Thomas Rhomberg(Harvard University), Silvia Martinelli(Max Planck Institute of Psychiatry), Antony Payton(University of Manchester), Andrew Robinson(Manchester Academic Health Science Centre), Valentin Stein(University of Bonn), Eicke Latz(University Hospital Bonn), William A. Carlezon(Harvard University), Felix Hausch(Technische Universität Darmstadt), Mathias V. Schmidt(Max Planck Institute of Psychiatry), Chris Murgatroyd(Manchester Metropolitan University), Sabina Berretta(Harvard University), Torsten Klengel(Harvard University), Harry Pantazopoulos(University of Mississippi Medical Center), Kerry J. Ressler(Harvard University), Nils C. Gassen(University of Bonn)
Nature Communications
March 25, 2024
Cited by 30Open Access
Full Text

Abstract

High levels of proinflammatory cytokines induce neurotoxicity and catalyze inflammation-driven neurodegeneration, but the specific release mechanisms from microglia remain elusive. Here we show that secretory autophagy (SA), a non-lytic modality of autophagy for secretion of vesicular cargo, regulates neuroinflammation-mediated neurodegeneration via SKA2 and FKBP5 signaling. SKA2 inhibits SA-dependent IL-1β release by counteracting FKBP5 function. Hippocampal Ska2 knockdown in male mice hyperactivates SA resulting in neuroinflammation, subsequent neurodegeneration and complete hippocampal atrophy within six weeks. The hyperactivation of SA increases IL-1β release, contributing to an inflammatory feed-forward vicious cycle including NLRP3-inflammasome activation and Gasdermin D-mediated neurotoxicity, which ultimately drives neurodegeneration. Results from protein expression and co-immunoprecipitation analyses of male and female postmortem human brains demonstrate that SA is hyperactivated in Alzheimer's disease. Overall, our findings suggest that SKA2-regulated, hyperactive SA facilitates neuroinflammation and is linked to Alzheimer's disease, providing mechanistic insight into the biology of neuroinflammation.


Related Papers

No related papers found

Powered by citation graph analysis